JESSICA HARRELL: Open Payments
NPI 1629764527 · MONTROSE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$358 in 14 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $191 · 2025 $358
Food & beverage: $358
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $88 |
| Medline Industries LP | 1 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $44 |
| Boston Scientific Corporation | 1 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Amgen Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: REXULTI, QULIPTA, Axonics, VRAYLAR, AIRSUPRA, Kerendia, EVENITY, BEXSERO.
Industry payments across CO — which companies pay providers there.
